COSMO Pharmaceuticals SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares COSMO Pharmaceuticals SA with three other
pharmaceutical manufacturers in Europe:
Cathay International Holdings Ltd
of UNITED KINGDOM
sales of £62.35 million [US$81.30 million]
of which 68%
(626.19 million Swedish Kronor [US$71.57 million]
of which 93%
was Consumer Healthcare), and
Eurobio Scientific SA
based in FRANCE
(59.07 million Euros [US$70.07 million]
COSMO Pharmaceuticals SA reported sales of 62.50 million Euro (US$74.13 million)
December of 2019.
decrease of 4.8%
versus 2018, when the company's sales were 65.62 million Euro.
Contributing to the drop in overall sales was the 68.4% decline
in Marketed Products Eleview, from 6.76 million Euro to 2.14 million Euro.
There were also decreases in sales in
Manufacturing of Mmx Products (down 8.4% to 25.21 million Euro)
Royalties (down 29.1% to 10.37 million Euro)
Related Services (down 23.9% to 1.74 million Euro)
However, these declines were partially offset by the increase in sales of
License Fees and Milestones (up 120.0% to 12.55 million Euro)
Manufacturing of Generic Products and Sp (up 6.2% to 8.26 million Euro)
Other Revenues From Sale (up 33.7% to 1.26 million Euro)